Abstract

A previous study identified that isoform 2 (Hcftt-2) of the 14-3-3 protein of Haemonchus contortus (H. contortus) could suppress immune functions of goat peripheral blood mononuclear cells (PBMCs) and might be a potential vaccine target, as neutralization of the protein function may enhance anti-parasite immunity. In this research, the recombinant Hcftt-2 was evaluated for its immunoprotective efficacy against H. contortus infection in goats. Five experimental goats were immunized twice with rHcftt-2 along with Freund’s adjuvant. The five immunized goats and five nonimmunized goats (adjuvant only) were challenged with 5000 L3-stage H. contortus larvae after 14 days of second immunization. Five nonimmunized and uninfected goats (adjuvant only) were set as the uninfected group. A significant increase in the serum immunoglobin G(IgG) and serum IgA levels were identified in the rHcftt-2 immunized animals. The mean eggs per gram in feces (EPG) and the worm burdens of rHcftt-2 immunized group were reduced by 26.46% (p < 0.05) and 32.33%, respectively. In brief, immunization of goats with rHcftt-2 induced moderate protection against H. contortus challenge.

Highlights

  • Helminth parasites are a worldwide problem, resulting in economic losses in the livestock industry.Haemonchus contortus is a highly pathogenic blood-sucking gastrointestinal nematode of the abomasum of small ruminants

  • Many native and recombinant proteins have been investigated in different immunization trials against H. contortus and most cases demonstrated variable reduction in fecal egg output and worm burdens [3,6,7,8,9]

  • Sera from infected goats revealed the presence of sero-reactive bandsthe at molecular weight of 48 kDa

Read more

Summary

Introduction

Helminth parasites are a worldwide problem, resulting in economic losses in the livestock industry. Haemonchus contortus is a highly pathogenic blood-sucking gastrointestinal nematode of the abomasum of small ruminants. Infections with this nematode can cause anemia, weight loss, and even death [1,2,3,4]. Current methods of prevention and control depend on the use of anthelmintics [3]. The appearance of anthelmintic-resistant strains, the environmental pollution, and the toxic residues in animal products has led to the urgent need for the development of more effective vaccines [5]. DNA vaccines have been tested and showed partial protection against

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call